Recombinant protein expression is a cornerstone of modern biotechnology, fueling advances in drug development, molecular ...

Pichia pastoris has emerged as a leading eukaryotic host for recombinant protein production, owing to its ability to perform complex post-translational modifications and grow to high cell densities ...

Reagents are expected to dominate with 27.2% market share in 2025, thanks to their essential role in protein expression ...

Vertex Pharmaceuticals (VRTX) announced that the FDA has granted breakthrough therapy designation to povetacicept for the treatment of IgAN. Pove ...

Pichia pastoris has emerged as a central microbial host for recombinant protein production, offering a unique balance of rapid growth, capacity for post‐translational modifications, and ease of ...